United Capital Financial Advisers, LLC Incyte Corp Transaction History

United Capital Financial Advisers, LLC

$11.7 Billion
Q4 2024

A detailed history of United Capital Financial Advisers, LLC transactions in Incyte Corp stock. As of the latest transaction made, United Capital Financial Advisers, LLC holds 6,107 shares of INCY stock, worth $383,397. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,107

Previous 6,683 8.62%

Holding current value

$383,397

Previous $441,000 4.54%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$65.08 - $83.38 $37,486 - $48,026	-576 Reduced 8.62%	6,107 $421,000
Q3 2024 Nov 12, 2024	SELL	$57.33 - $68.61 $19,778 - $23,670	-345 Reduced 4.91%	6,683 $441,000
Q2 2024 Aug 14, 2024	BUY	$51.18 - $63.75 $54,762 - $68,212	1,070 Added 17.96%	7,028 $426,000
Q1 2024 May 15, 2024	BUY	$56.55 - $66.59 $28,840 - $33,960	510 Added 9.36%	5,958 $339,000
Q4 2023 Feb 14, 2024	BUY	$52.16 - $64.19 $284,167 - $349,707	5,448 New	5,448 $342,000
Q2 2023 Aug 14, 2023	SELL	$60.95 - $75.51 $105,748 - $131,009	-1,735 Reduced 28.56%	4,340 $270,000
Q1 2023 Aug 14, 2023	BUY	$70.23 - $86.01 $121,849 - $149,227	1,735 Added 39.98%	6,075 $439,000
Q1 2023 May 15, 2023	SELL	$70.23 - $86.01 $233,936 - $286,499	-3,331 Reduced 35.41%	6,075 $439,000
Q4 2022 Feb 14, 2023	SELL	$67.18 - $84.11 $6,382 - $7,990	-95 Reduced 1.0%	9,406 $755,000
Q3 2022 Nov 14, 2022	SELL	$66.18 - $82.86 $8,669 - $10,854	-131 Reduced 1.36%	9,501 $633,000
Q2 2022 Aug 11, 2022	BUY	$66.18 - $83.18 $463 - $582	7 Added 0.07%	9,632 $732,000
Q1 2022 May 16, 2022	SELL	$66.02 - $79.71 $23,503 - $28,376	-356 Reduced 3.57%	9,625 $764,000
Q4 2021 Feb 14, 2022	SELL	$63.34 - $74.11 $126,806 - $148,368	-2,002 Reduced 16.71%	9,981 $733,000
Q3 2021 Nov 15, 2021	SELL	$68.67 - $84.02 $123,125 - $150,647	-1,793 Reduced 13.02%	11,983 $824,000
Q2 2021 Aug 13, 2021	SELL	$79.87 - $87.53 $58,624 - $64,247	-734 Reduced 5.06%	13,776 $1.16 Million
Q1 2021 May 14, 2021	BUY	$76.02 - $100.5 $59,143 - $78,189	778 Added 5.67%	14,510 $1.18 Million
Q4 2020 Feb 17, 2021	SELL	$80.74 - $97.7 $191,999 - $232,330	-2,378 Reduced 14.76%	13,732 $1.19 Million
Q3 2020 Nov 13, 2020	BUY	$85.07 - $109.69 $6,890 - $8,884	81 Added 0.51%	16,110 $1.45 Million
Q2 2020 Aug 13, 2020	BUY	$74.18 - $108.93 $11,127 - $16,339	150 Added 0.94%	16,029 $1.67 Million
Q1 2020 May 15, 2020	SELL	$63.18 - $85.97 $66,212 - $90,096	-1,048 Reduced 6.19%	15,879 $1.16 Million
Q4 2019 Feb 14, 2020	SELL	$73.04 - $95.72 $9,349 - $12,252	-128 Reduced 0.75%	16,927 $1.48 Million
Q3 2019 Nov 14, 2019	BUY	$72.82 - $86.52 $1.24 Million - $1.48 Million	17,055 New	17,055 $1.27 Million
Q2 2019 Aug 13, 2019	SELL	$73.52 - $88.7 $205,782 - $248,271	-2,799 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$63.56 - $88.17 $177,904 - $246,787	2,799 New	2,799 $241,000
Q3 2017 Nov 14, 2017	SELL	$109.15 - $138.27 $177,150 - $224,412	-1,623 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	1,623	1,623 $204,000

Others Institutions Holding INCY

# of Institutions

707

Shares Held

189M

Call Options Held

909K

Put Options Held

489K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $14B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on United Capital Financial Advisers, LLC with notifications on news.

Account

United Capital Financial Advisers, LLC Incyte Corp Transaction History